A state-of-the-art review on fucoidan as an antiviral agent to combat viral infections.
Carbohydr Polym
; 291: 119551, 2022 Sep 01.
Article
in English
| MEDLINE | ID: covidwho-1814196
ABSTRACT
As a significant public health hazard with several drug side effects during medical treatment, searching for novel therapeutic natural medicines is promising. Sulfated polysaccharides from algae, such as fucoidan, have been discovered to have a variety of medical applications, including antibacterial and immunomodulatory properties. The review emphasized on the utilization of fucoidan as an antiviral agent against viral infections by inhibiting their attachment and replication. Moreover, it can also trigger immune response against viral infection in humans. This review suggested to be use the fucoidan for the potential protective remedy against COVID-19 and addressing the antiviral activities of sulfated polysaccharide, fucoidan derived from marine algae that could be used as an anti-COVID19 drug in near future.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antiviral Agents
/
COVID-19 Drug Treatment
Limits:
Humans
Language:
English
Journal:
Carbohydr Polym
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS